CTY: Orth Andrew C. reports a stock award
By AlphaYouPublished Form 4
ORTH ANDREW C.
Reporting filer
Orth Andrew C. reports a stock award, not an open-market purchase or sale, in City Therapeutics, Inc.. Form 4 filed Oct 19, 2026 lists 1 entry.
- Disclosed
- Oct 19, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | ORTH ANDREW C. | 2026-10-19 | A | Grant or award | 77979 | 0 | 77,979 | 0 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- ORTH ANDREW C.
- Date
- 2026-10-19
- Code
- A
- Action
- Grant or award
- Quantity
- 77979
- Price
- 0
- Following holdings
- 77,979
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 0.92
- transaction Date: 2026-10-19
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 77979
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2034-12-10
- underlying Security Title: Common Stock
- underlying Security Shares: 77979
- shares Owned Following Transaction: 77979
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- ORTH ANDREW C.: President & CEO, Director.
- F1: This stock option was originally granted to the Reporting Person on December 11, 2024. The shares vested in full upon closing of the Issuer's initial public offering on October 19, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.